Literature DB >> 26300681

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

E Tsvetkova1, S Sud1, N Aucoin2, J Biagi3, R Burkes4, B Samson5, S Brule1, C Cripps1, B Colwell6, C Falkson3, M Dorreen6, R Goel1, F Halwani1, J Maroun1, N Michaud7, M Tehfe8, M Thirlwell9, M Vickers1, T Asmis1.   

Abstract

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Montreal, Quebec, 23-25 October 2014. Expert radiation, medical, and surgical oncologists and pathologists involved in the management of patients with gastrointestinal malignancies participated in presentations and discussions resulting in consensus statements on such hot topics as management of neuroendocrine tumours, advanced and metastatic pancreatic cancer, and metastatic colorectal cancer.

Entities:  

Keywords:  Neuroendocrine tumours; RAS testing; chemotherapy; colorectal cancer; pancreatic cancer; radiation therapy; screening

Year:  2015        PMID： 26300681      PMCID： PMC4530828          DOI： 10.3747/co.22.2603

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


  88 in total

Review 1.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

Review 2.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 3.  Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials.

Authors:  M J Sorich; M D Wiese; A Rowland; G Kichenadasse; R A McKinnon; C S Karapetis
Journal:  Ann Oncol       Date:  2014-08-12       Impact factor: 32.976

4.  Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.

Authors:  David R Fogelman; Robert A Wolff; Scott Kopetz; Milind Javle; Charles Bradley; Isabel Mok; Fernando Cabanillas; James L Abbruzzese
Journal:  Anticancer Res       Date:  2011-04       Impact factor: 2.480

5.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

6.  Aggressive surgery for metastatic liver neuroendocrine tumors.

Authors:  Jeffrey A Norton; Robert S Warren; Mary G Kelly; Marlene B Zuraek; Robert T Jensen
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

Review 7.  The diagnosis and medical management of advanced neuroendocrine tumors.

Authors:  Gregory A Kaltsas; G Michael Besser; Ashley B Grossman
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

8.  Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.

Authors:  W D Denney; W E Kemp; L B Anthony; J A Oates; B F Byrd
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

Review 10.  Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

Authors:  Øyvind Holme; Michael Bretthauer; Atle Fretheim; Jan Odgaard-Jensen; Geir Hoff
Journal:  Cochrane Database Syst Rev       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.